The primary role of cardiologists in cardiovascular prevention
Onder, L.; Nicolosi, G.Luigi.
Giornale Italiano di Cardiologia 11(5 Suppl. 3): 131s-132s
2010
ISSN/ISBN: 1827-6806 PMID: 20879500 Document Number: 646603
Document emailed within 1 workday
Related Documents
1999: Canadian Cardiovascular Society 1998 Consensus Conference on the Prevention of Cardiovascular Diseases: The Role of the Cardiovascular Specialist Canadian Journal of Cardiology 15 Suppl G: 1gDanchin, N.; Amelineau, E.; Quentzel, S.; Cambou, J.P. 2006: Role of cardiologists in control of risk factors and prescription of secondary-preventive drugs in elderly patients with atherosclerotic cardiovascular disease. The French ELIAGE-MG survey Annales de Cardiologie et d'Angeiologie 55(1): 17-21
Nordt, T. 2001: Primary prevention of cardiovascular events by ASS and vitamin E. PPP--Primary Prevention Project Der Internist 42(12): 1705-1707
Chopeĭ, I.V.; Rosul, M.M.; Hechko, M.M.; Chubirko, K.I.; Korabel'shchykova, M.O.; Ivan'o, N.V. 2014: Cardiovascular continuum: the role of the family doctor in prevention of cardiovascular diseases Wiadomosci Lekarskie 67(2 Pt 2): 243-247
Agarwal, R.; Sola, S. 2007: Cardiovascular MRI: what cardiologists need to know Indian Heart Journal 59(1): 69-76
Garrett, R.E. 1986: Primary prevention of cardiovascular disease Journal of Family Practice 22(3): 222 224
Miser, W.Fred. 2011: Appropriate aspirin use for primary prevention of cardiovascular disease American Family Physician 83(12): 1380-1386
Collins, P.; Rosano, G.; Casey, C.; Daly, C.; Gambacciani, M.; Hadji, P.; Kaaja, R.; Mikkola, T.; Palacios, S.; Preston, R.; Simon, T.; Stevenson, J.; Stramba-Badiale, M. 2007: Management of cardiovascular risk in the peri-menopausal woman--a consensus statement of European cardiologists and gynaecologists Kardiologia Polska 65(11): 1331-46; Discussion 1347-49
Béliard-Lasserre, S. 2016: Should we prescribe statins for primary prevention of cardiovascular risk? Rather yes La Revue du Praticien 66(3): 332-334
Chazov, E.I. 2002: Problems in primary and secondary prevention of cardiovascular diseases Terapevticheskii Arkhiv 74(9): 5-8
García-Palmieri, M.R. 2000: Primary and secondary prevention of cardiovascular disease in the elderly Boletin de la Asociacion Medica de Puerto Rico 92(1-3): 3-8
Brohet, C. 1995: Risk factors and primary prevention of cardiovascular disease Journal de Pharmacie de Belgique 50(1): 20-24
Volpe, M.; Tocci, G. 2012: Global cardiovascular risk management in primary prevention Current Vascular Pharmacology 10(6): 709-711
Schlierf, G. 1980: Primary and secondary prevention of cardiovascular diseases - metabolic aspects Verhandlungen der Deutschen Gesellschaft für Innere Medizin 86: 546-550
Fretheim, A.; Bjørndal, A.; Oxman, A.D.; Dyrdal, A.; Golding, M.; Ose, L.; Reikvam, A.; Teisberg, P. 2002: Which cholesterol-lowering drugs should be used in the primary prevention of cardiovascular disease? Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 122(23): 2287-2288
Sobieszczańska, Młgorzata.; Kałka, D.; Pilecki, W.; Adamus, J. 2009: Physical activity in basic and primary prevention of cardiovascular disease Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 26(156): 659-664
Richard, J.L.; Delahaye, F. 1998: Cardiovascular prevention, primary or secondary, in high risk patients Archives des Maladies du Coeur et des Vaisseaux 91(12): 1495-1502
Tkacheva, O.N.; Sharashkina, N.V. 2010: Possibilities of ramipril in primary and secondary prevention of cardiovascular diseases Kardiologiia 50(8): 63-66
Wander, G.S.; Hukkeri, M.Yunus.Khan.; Yalagudri, S.; Mahajan, B.; Panda, A.Toppo. 2018: Rosuvastatin: Role in Secondary Prevention of Cardiovascular Disease Journal of the Association of Physicians of India 66(3): 70-74
Nanchen, D.; Chiolero, A.; Marques-Vidal, P-Manuel.; Cornuz, J.; Waeber, Gérard.; Vollenweider, P.; Rodondi, N. 2010: Statin prescription in primary prevention: which cardiovascular risk score should be used in Switzerland? Revue Medicale Suisse 6(239): 488-90 492-3